Text available as:

Shown Here:Introduced in House (03/27/2017)

115th CONGRESS1st Session

H. R. 1732

To amend the Controlled Substances Act to add certain synthetic substances to schedule I, and for
other purposes.

IN THE HOUSE OF REPRESENTATIVES

March 27, 2017

Mr. Dent (for himself, Mr. Himes, and Mr. Barletta) introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such
provisions as fall within the jurisdiction of the committee concerned

A BILL

To amend the Controlled Substances Act to add certain synthetic substances to schedule I, and for
other purposes.

Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,

(a) In general.—Not later than 180 days after the date of enactment of this Act, the Attorney General of the United States shall update schedule I under section 202(c) of the Controlled Substances Act (21 U.S.C. 812(c)) to include, unless specifically exempted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of a substance listed in paragraphs (1) through (9), or which contains the salts, isomers, and salts of isomers thereof whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation. The substances referred to in the preceding sentence are the following:

(1) PHENYLALKYLAMINES.—The substances listed in this paragraph consist of the following phenylalkylamines:

(b) Inapplicability of other process and considerations.—The Attorney General of the United States may carry out subsection (a) without regard to the process and considerations that are otherwise applicable under section 201 of the Controlled Substances Act (21 U.S.C. 811) for adding, removing, or transferring controlled substances to, from, or among the schedules under section 202(c) of such Act (21 U.S.C. 812(c)).

(c) Exemption for research.—

(1) EXEMPTION.—Notwithstanding subsection (a), a material, compound, mixture, or preparation described in such subsection shall not be treated as a controlled substance for purposes of the Controlled Substances Act (21 U.S.C. 801 et seq.) so long as the material, compound, mixture, or preparation is manufactured, distributed, and used exclusively for qualified research.

(2) QUALIFIED RESEARCH DEFINED.—In this subsection, the term “qualified research” means research (as such term is used in section 303(f) of the Controlled Substances Act (21 U.S.C. 823(f))) that is conducted by a practitioner who is registered under such section 303(f) to conduct research with controlled substances in schedule II, III, IV, or V (as described in such section 303(f)).

(d) Rule of construction.—Nothing in this section shall be construed to limit or affect the authority of the Attorney General of the United States to add, remove, or transfer controlled substances to, from, or among the schedules under section 202(c) of the Controlled Substances Act (21 U.S.C. 812(c)), including controlled substances that have been added to a schedule pursuant to subsection (a).